Skip to Content

Invenomic Institutional BIVIX Fund Analysis

| Medalist Rating as of | See Invenomic Investment Hub

Morningstar’s Analysis BIVIX

Will BIVIX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

A sound investment process and strong management team underpin Invenomic Institutional's Morningstar Medalist Rating of Bronze.

null Morningstar Manager Research

Morningstar Manager Research

Summary

Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the most expensive quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor